Resultados de procura - Christopher A Lamb
- Mostrando 1 - 20 Resultados de 48
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Immune-related adverse events in checkpoint blockade: Observations from human tissue and therapeutic considerations por Kristian C. Williams, Abigail Gault, Amy E. Anderson, Christopher J. Stewart, Christopher A Lamb, R. Ally Speight, Neil Rajan, Ruth Plummer, Arthur G. Pratt
Publicado 2023Revisão -
13
Strain-specific impacts of probiotics are a significant driver of gut microbiome development in very preterm infants por Lauren C. Beck, A Masi, Gregory R. Young, Tommi Vatanen, Christopher A Lamb, Rachel Smith, Jonathan Coxhead, Alana Butler, Benjamin J. Marsland, Nicholas D. Embleton, Janet Berrington, Christopher J. Stewart
Publicado 2022Artigo -
14
Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation por Graeme O’Boyle, Christopher R. Fox, Hannah R. Walden, Joseph D. P. Willet, Emily Mavin, Dominic Hine, Jeremy M. Palmer, Catriona E. Barker, Christopher A Lamb, Simi Ali, John A. Kirby
Publicado 2012Artigo -
15
Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease por Robin Dart, Iva Zlatareva, Pierre Vantourout, Efstathios Theodoridis, Ariella Amar, Shichina Kannambath, Philip East, Timothy Recaldin, John Mansfield, Christopher A Lamb, Miles Parkes, Peter M. Irving, Natalie J. Prescott, Adrian Hayday
Publicado 2023Artigo -
16
The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease por Nicholas A. Kennedy, Christopher A Lamb, Susan H. Berry, Alan W. Walker, John Mansfield, Miles Parkes, Rachel Simpkins, Mark Tremelling, Sarah Nutland, Julian Parkhill, Chris Probert, Georgina L. Hold, Charlie W. Lees
Publicado 2018Artigo -
17
Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis por A Masi, Nicholas D. Embleton, Christopher A Lamb, Gregory R. Young, Claire Granger, Julia A. Najera, Daniel P. Smith, Kristi L. Hoffman, Joseph F. Petrosino, Lars Bode, Janet Berrington, Christopher J. Stewart
Publicado 2020Artigo -
18
The Impact of<i>NOD2</i>Genetic Variants on the Gut Mycobiota in Crohn’s Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation por Andrew Nelson, Christopher J. Stewart, Nicholas A. Kennedy, John K. Lodge, Mark Tremelling, Chris Probert, Miles Parkes, John Mansfield, Darren Smith, Georgina L. Hold, Charlie W. Lees, Simon H. Bridge, Christopher A Lamb
Publicado 2020Artigo -
19
Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding Trials por Nicholas D. Embleton, Janet Berrington, Jon Dorling, Andrew K Ewer, Edmund Juszczak, John A. Kirby, Christopher A Lamb, Clare Lanyon, William McGuire, C Probert, Stephen Rushton, Mark Shirley, Christopher J. Stewart, Stephen Cummings
Publicado 2017Artigo -
20
Inflammatory bowel disease patient‐reported quality assessment should drive service improvement: a national survey of <scp>UK IBD</scp> units and patients por A. B. Hawthorne, Jackie Glatter, Jonathan Blackwell, Rachel Ainley, Ian Arnott, Kevin Barrett, Graham Bell, Matthew Brookes, Melissa Fletcher, Rafeeq Muhammed, Alan Nevill, Jonathan Segal, Christian P. Selinger, Anja St Clair Jones, Lisa Younge, Christopher A Lamb
Publicado 2022Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Disease
Internal medicine
Biology
Immunology
Inflammatory bowel disease
Genetics
Pathology
Ulcerative colitis
Gastroenterology
Biochemistry
Gene
Crohn's disease
Immune system
Infliximab
Cell biology
Vedolizumab
Antibody
Gut flora
Microbiology
Tumor necrosis factor alpha
Cell
Chemistry
Coronavirus disease 2019 (COVID-19)
Family medicine
Infectious disease (medical specialty)
Inflammation
Intensive care medicine
Receptor
Vaccination